CLASS II ONGOING Device recall · Reported 22 Mar 2023 · FDA Enforcement Report

Fusion Bioline Vascular Graft recalled by Maquet Cardiovascular

Maquet Cardiovascular is recalling Fusion Bioline Vascular Graft, distributed nationwide in the US. The recall was initiated on 30 Jan 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI 00384409005942 Lot 25162546
Quantity recalled1 (US)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1245-2023
FDA event ID
91671
Recalling firm
Maquet Cardiovascular, Wayne, NJ
Classification
Class II
Status
Ongoing
Recall initiated
30 Jan 2023
FDA classified
10 Mar 2023
Reported
22 Mar 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

30 Jan 2023Recall initiated by company
10 Mar 2023Classified by FDA+39 days
22 Mar 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

One (1) Fusion Bioline Vascular graft from lot 25162546, which failed guideline straightness testing, was intermingled with lot 25162549 and distributed to customers. Use of the affected graft may result in reduction of blood flow or unwanted tension causing bleeding and the formation of a pseudo-aneurysm.

Product as listed by the FDA

Fusion Bioline Vascular Graft, Part number M00201503046B0

Where it was distributed

US Nationwide distribution in the states of FL, IN, LA, MI, MO, NC, NV, NY, PA, TN, TX, VA, WA.

Nationwide FloridaIndianaLouisianaMichiganMissouriNorth CarolinaNevadaNew YorkPennsylvaniaTennesseeTexasVirginiaWashington

Questions about this recall

Why was it recalled?

One (1) Fusion Bioline Vascular graft from lot 25162546, which failed guideline straightness testing, was intermingled with lot 25162549 and distributed to customers. Use of the affected graft may result in reduction of blood flow or unwanted tension causing bleeding and the formation of a pseudo-aneurysm.

Which lots are affected?

UDI-DI 00384409005942 Lot 25162546

Where was it sold?

US Nationwide distribution in the states of FL, IN, LA, MI, MO, NC, NV, NY, PA, TN, TX, VA, WA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Maquet Cardiovascular

All 252

Other Heart & Vascular Devices recalls

All 6,199